No Picture
News

Biofourmis Selected by American College of Cardiology as Exclusive Virtual Care Platform to Drive TRANSFORM3 Study Focused on Closing Practice Gaps for Heart Conditions

Biofourmis Care, a comprehensive care management platform including virtual multidisciplinary care teams, to be evaluated against in-person care among underserved patients with chronic cardiovascular conditions BOSTON, May 12, 2022 /PRNewswire/ — Biofourmis, a Boston-based global leader… Click here to view original post… […]

[adinserter block="3"]
No Picture
News

Stealth BioTherapeutics Receives Orphan Drug Designation from FDA for Elamipretide for Treatment of Duchenne Muscular Dystrophy

Pre-IND meeting request granted by FDA’s Division of Neurology I BOSTON, May 12, 2022 /PRNewswire/ — Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving… Click here to view original post… […]

No Picture
News

Melmark CEO Named Financial Strength and Overall Winner of the 2022 CBIZ Women Transforming Business Awards

ANDOVER, Mass. and BERWYN, Pa. and CHARLOTTE, N.C. , May 11, 2022 /PRNewswire/ — Rita M. Gardner, President and CEO of Melmark, Inc. has recently been named the Overall Winner and Financial Strength Category Winner of the 2022 CBIZ Inc. Women Transforming Business Awards. Martha Stewart… Click here to view original post… […]

[adinserter block="3"]
No Picture
News

Fusion Pharmaceuticals to Present at the Guggenheim Securities Radiopharmaceuticals Day

HAMILTON, ON and BOSTON, May 11, 2022 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will participate in a fireside chat at… Click here to view original post… […]

[adinserter block="3"]